NCT02267629View on ClinicalTrials.gov

Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Obsessive-Compulsive Disorder (OCD)
Interventions
DRUG

Rapastinel (formerly GLYX-13)

10 mg/kg IV Rapastinel (formerly GLYX-13)

Trial Locations (1)

10032

New York State Psychiatric Insitute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT02267629 - Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder | Biotech Hunter | Biotech Hunter